Functional and binding characterization of endothelin receptors in human bronchus: Evidence for a novel endothelin B receptor subtype?

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 669-677

  Hay, Douglas W P ^a   Luttmann, Mark A ^a   Pullen, Mark A ^a   Nambi, Ponnal ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; RECEPTOR SUBTYPE; RES 701 1; SARAFOTOXIN S6C; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ARTICLE; BRONCHUS MUSCLE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; SMOOTH MUSCLE CONTRACTION;

BRONCHI; BRONCHOCONSTRICTION; CELL MEMBRANE; ENDOTHELIN-1; ENDOTHELIN-3; HUMANS; RADIOLIGAND ASSAY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0031951774     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arai H, Hori S, Aramori I, Ohkubo H and Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732.
2. Bax WA and Saxena PR (1994) The current endothelin receptor classification: time for reconsideration? Trends Pharmacol Sci 15:379-386.
3. Douglas SA, Beck GR Jr, Elliott JD and Ohlstein EH (1995) Pharmacological evidence for the presence of three distinct endothelin receptor subtypes in the rabbit lateral saphenous vein. Br J Pharmacol 114:1529-1540.
4. B) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus. Br J Pharmacol 118:1873-1874.
5. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi, Br J Pharmacol 117:995-999.
6. Gellai M, Fletcher T, Pullen M and Nambi P (1996) Evidence for the existence of endothelin B receptor subtypes and their physiological roles in the rat. Am J Physiol 271: 254-R261.
7. Goldie RG, Henry PJ, Knott PG, Self GJ, Luttmann MA and Hay DWP (1995) Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways. Am J Respir Crit Care Med 152:1653-1658.
8. Hay DWP and Goldie RG (1995) Role of endothelin in pulmonary diseases, in Endothelin: Role of Health and Disease (Gulati A ed) pp 251-273, Harwood Academic, Amsterdam.
9. Hay DWP, Henry PJ and Goldie RG (1993a) Endothelin and the respiratory system. Trends Pharmacol Sci 14:29-32.
10. Hay DWP, Hubbard WC and Undem BJ (1993b) Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol 110:392-398.
11. Hay DWP, Luttmann MA, Hubbard WC and Undem BJ (1993c) Endothelin receptor subtypes in guinea-pig and human pulmonary tissues. Br J Pharmacol 110:1175-1183.
12. B) receptors in rabbit isolated pulmonary artery and bronchus. Br J Pharmacol 118: 1209-1217.
13. Hiley CR, McStay MKG, Bottrill FE and Douglas SA (1992) Cross-desensitization studies with endothelin isopeptides in the rat isolated superior mesenteric arterial bed. J Vasc Res 29:135, 1992.
14. Huggins JP, Pelton JT and Miller RE (1993) The structure and specificity of endothelin receptors: Their importance in physiology and medicine. Pharmacol Ther 59:55-123.
15. A receptor. Life Sci 50:247-255.
16. B) receptors. Life Sci 51:47-52.
17. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K and Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867.
18. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M and Yano M (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci 91:4892-4896.
19. Kenakin TP, Bond RB and Bonner TI (1992) Definition of pharmacological receptors. Pharmacol Rev 44:351-362.
20. Kizawa Y, Nakajima Y, Nakano J, Uno H, Sano M and Murakami H (1994) Pharmacological profiles of contractile endothelin receptors in guinea pig hilar bronchus. Receptor 4:269-276.
21. Knott PG, D'Aprile AC, Henry PJ, Hay DWP and Goldie RG (1995) Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol 114:1-3.
22. Marsault R, Vigne P, Breittmayer JP and Frelin C (1991) Kinetics of vasoconstrictor action of endothelins. Am J Physiol 261:C986-C993.
23. Masaki T, Yanagisawa M and Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391-421.
24. Michael JR and Markewitz BA (1996) Endothelins and the lung. Am J Respir Crit Care Med 154:555-581.
25. B-selective agonist, displays species differences in its binding characteristics. Neuropeptides 28:191-196.
26. 125I-IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Exp Ther 268:202-207.
27. Ohlstein EH, Douglas SA, Nambi P, Edwards RM, Lago MA, Gleason JG, Ruffolo RR Jr, Feuerstein G and Elliott JD (1994a) Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther 271:762-768.
28. Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, Cousins RD, Gao A, Frazee JS, Peishoff CE, Bean JA, Eggleston DS, Elshourbagy NA, Kumar C, Lee JA, Yue T-L, Louden C, Brooks DP, Weinstock J, Feuerstein G, Poste G, Ruffolo RR Jr, Gleason JG and Elliott JD (1994b) SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci 91:8052-8056.
29. Ohlstein EH, Nambi P and Ruffolo RR Jr (1995) Endothelin receptor subclassification, in Endothelin Receptors. From the Gene to the Human (Ruffolo RR Jr ed) pp 15-36, CRC Press, Boca Raton, FL.
30. A receptor-mediated phenomenon. Br J Pharmacol 118:191-197.
31. Robertson MJ, Dougall IG, Harper D, McKechnie KCW and Leff P (1994) Agonist-antagonist interactions at the angiotensin receptors: application of a two-state receptor model. Trends Pharmacol Sci 15:364-369.
32. Sakurai T, Yanagisawa M and Masaki T (1992) Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108.
33. Sakurai T, Yanagisawa M, Takuwa Y, Miyasaki H, Kimura S, Goto K and Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735.
34. Sokolovsky M, Ambar I and Galron R (1992) A novel subtype of endothelin receptors. J Biol Chem 267:20551-20554.
35. B receptor. Biochem Biophys Res Commun 184:953-959.
36. Tanaka T, Tsukuda E, Nozawa M, Nonaka H, Ohno T, Kase H, Yamada K and Matsuda Y (1994) RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol 45:724-730.
37. 125I]-endothelin-1 binding data. Life Sci 51:1869-1876.
38. Warner TD, Allcock GH, Mickley EJ, Corder R and Vane JE (1993) Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J Cardiovasc Pharmacol 22 (suppl 8):S117-S120.
39. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV and Clineschmidt BV (1991) Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556-561.
40. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T (1988) A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.